Lupin Limited has informed the Exchange regarding a press release dated April 12, 2024, titled "U.S. FDA Completes Inspection of Lupin s Dabhasa Facility with No Observations.".
Lupin Limited has informed the Exchange regarding a press release dated April 12, 2024, titled "U.S. FDA Completes Inspection of Lupin s Dabhasa Facility with No Observations.".